OncoDaily Newsletter

Subscribe to our newsletter

Subscribe

Participating in the IARC Governing Council Meeting in Lyon - UICC

Muna Al-Khaifi: Translating Evidence Into Everyday Practice for Cancer-Related Fatigue

Strengthening or Weakening Tobacco Taxation? The EU Policy Debate

E. Anders Kolb: Blood Cancer United Preserves Access to Luveltamab Tazevibulin for Children with AML

Nivolumab Plus Ipilimumab With Chemotherapy Shows Long-Term OS Advantage in PD-L1-Negative Advanced NSCLC

Oncology News, Insights, Stories by OncoDaily

EHA 2026 - OncoDaily
Not To Miss

25 Posts Not To Miss From EHA 2026

bigr europe
Not To Miss

Top Growing Medical Universities in Europe: 2026 Edition by BIGR

Dwayne Johnsons testicular lump
Celebrities and Cancer

Dwayne Johnson’s Alarming Health Scare: The Rock’s Testicular Lump That Couldn’t Be Ignored

Remembering Phuong Ly-Gallagher: The Advocate Who Never Stopped Showing Up

Prof. Claire Harrison Honored with 2026 EHA Lifetime Achievement Award

INAVO120 Safety Analysis Shows Manageable Profile of Inavolisib Plus Palbociclib–Fulvestrant in PIK3CA-Mutated Advanced Breast Cancer

MonumenTAL-3 Supports Tal-D With or Without Pom as a New Standard of Care in 2L RRMM

Hesham ElGhazaly: Celebrating 60 Years of Translating Science Into Impactful Policy at IARC

Anbenitamab Plus HB1801 Meets Phase III Endpoint in First-Line HER2-Positive Advanced Breast Cancer

J&J Buys Firefly Bio, and the Conjugate Land Grab Finds a New Frontier

Voices
David Entwistle

David Entwistle: First Patient Receives Proton Therapy at Stanford’s Innovative Ultracompact Facility

Kate Ayers: Shaping the Next Generation of Scientists Through Research and Mentorship

Talha Badar: Great Science, Great Teamwork, Great Connections

Jan Geissler on the Evolving Role of Patient Advocates at EHA2026

Reducing Cancer Risk for People With Albinism Through Research and Collaboration - IARC

Yin Ting Cheung: MASCC 2026 and the World Cup Reunite for Another Memorable Conference Season

Shushan Hovsepyan: Happy to Join the NCCN Webinar on The Growing Cancer Burden in Young Adults

FDA Approvals
Decnupaz

FDA Approved Decnupaz (pivekimab sunirine-pvzy), the First ADC for Adults With BPDCN

FDA Approves FoundationOne CDx as Companion Diagnostic for TEPMETKO in METex14 NSCLC

FDA approved Atezolizumab for adjuvant treatment of MDR–positive MIBC

FDA Grants Approval for Oral Decitabine/Cedazuridine With Venetoclax in Newly Diagnosed AML

FDA Greenlit New Pancreatic Cancer Drug Daraxonrasib For Expanded Access

FDA Grants Full Approval of Tecartus for Relapsed/Refractory Mantle Cell Lymphoma in Adults

FDA Grants Fast Track Designation to TRI-611 in ALK-Positive NSCLC

OncoDaily 100
100 Xfluencers in Prostate Cancer

100 Xfluencers in Prostate Cancer: Key Opinion Leaders to follow on X (Twitter) in 2025

The 100 Most Influential CEOs in Oncology in 2025 (Full List)

The 100 Most Influential People in Oncology in 2025 (Full List)

100 Influential Women in Oncology: Key Opinion Leaders to Follow on Social Media in 2025

100 Influential Women in Oncology: Key Opinion Leaders to follow on Social Media in 2024

Top 100 Xfluencers in Lung Cancer: Key Opinion Leaders to Follow on X (Twitter) in 2024

Top 100 Xfluencers in Breast Cancer: Key Opinion Leaders to Follow on X (Twitter) in 2024

Celebrities and Cancer

OncoCalendar

Shift: AI and Mental Health Innovations in Oncology

17 Jun
Mental Health

Australian and New Zealand Society of Palliative Medicine Conference (ANZSPM 2026)

Australian and New Zealand Society of Palliative Medicine

24 Sep
Palliative Medicine

22nd Biennial Meeting of the European Society for Immunodeficiencies (ESID 2026)

KENES Group

14 Oct
ESID 2026

13th International Paediatric Renal Tumours Biology Conference, London, 11-13th October 2026

International Society of Paediatric Oncology (SIOP)

11 Oct
Renal Tumours

The 16th World Clinical Biomarkers and Companion Diagnostics Summit

Hanson Wade

05 Oct
The 16th World Clinical Biomarkers and Companion Diagnostics Summit

Immune-oncology
Sipuleucel-T and IL-7

Sipuleucel-T With or Without IL-7 in mCRPC: FDG PET/CT Offers Early Imaging Insights

Immunotherapy in Head and Neck Cancer

10 Immunotherapy Posts Not To Miss From ASCO 2026

Immunotherapy for Early-Stage Cutaneous Squamous Cell Carcinoma

AI-Based Histopathology Analysis Predicts Checkpoint Inhibitor Response in Advanced Melanoma

AEGEAN Trial: Durvalumab Reshapes the Tumor Microenvironment in Resectable NSCLC

ARCHER Trial: Prophylactic ALK Resistance Vaccine in Advanced ALK-Positive NSCLC

Gastrointestinal-Oncology
OCLURANDOM

OCLURANDOM: [177Lu]Lu-dota-tate Shows Antitumor Activity in Progressive Metastatic Pancreatic Neuroendocrine Tumors

10 Must-Read Posts In GI Oncology This Week

Vopimetostat Plus Daraxonrasib Shows 92% ORR in MTAP-Deleted, RAS-Mutant mPDAC

PRODIGE 61–FUNGEMAX: Sequential Chemotherapy in First-Line Metastatic Pancreatic Cancer

TESAR Trial: Adjuvant ChemoRT vs Completion TME After Local Excision for Early Rectal Cancer

IMMUNIB Study Uptades: Nivolumab Plus Lenvatinib in Unresectable HCC

REAL TAB: Trastuzumab-Based Therapy Associated With Improved Survival in HER2-Positive Biliary Tract Cancers

Breast-Oncology
INAVO120

INAVO120 Safety Analysis Shows Manageable Profile of Inavolisib Plus Palbociclib–Fulvestrant in PIK3CA-Mutated Advanced Breast Cancer

Anbenitamab Plus HB1801 Meets Phase III Endpoint in First-Line HER2-Positive Advanced Breast Cancer

BEGONIA Arm 6: Durvalumab Plus T-DXd Shows Activity in HER2-Low Breast Cancer

Carboplatin Improves Event-Free Survival in Early Triple-Negative Breast Cancer: Results From PEARLY Trial

Breast Cancer Research Highlights: Key Publications From May 29 To June 5, 2026

ESMO Updates Metastatic Breast Cancer Guideline: A More Molecular, Subtype-Driven Roadmap For Care

FAST-Forward 10-Year Results Support 1-Week Breast Radiotherapy As Standard Of Care

Lung-Oncology
PD-L1-Negative Advanced NSCLC

Nivolumab Plus Ipilimumab With Chemotherapy Shows Long-Term OS Advantage in PD-L1-Negative Advanced NSCLC

ASCO Living Guideline 2026.3.0 Updates Treatment Roadmap for Stage IV NSCLC With Driver Alterations

Early ctDNA May Stratify Survival In Locally Advanced And Oligometastatic NSCLC Treated With Radiotherapy

High PD-L1 Expression Linked To Shorter PFS With First-Line ALK TKIs In ALK-Rearranged NSCLC

Plasma Signals May Open A New Era Of Lung Cancer Prevention

Chemoimmunotherapy May Improve Survival Over PD-(L)1 Monotherapy in PD-L1–High Advanced NSCLC

CHRYSALIS-2 Trail at ASCO 2026: Amivantamab Plus Lazertinib in Atypical EGFR-Mutated NSCLC

OncoDaily TV
Oncology's Greatest Threat: A System in Crisis

Oncology’s Greatest Threat: A System in Crisis

OncoDaily Grand Rounds at ASCO 2026: Sarcoma Edition: Highlights of the event

OncoDaily Grand Rounds at ASCO 2026: Sarcoma Edition: Highlights of the event

How Desmond Yip Helped Build Cancer Care in the Solomon Islands

How Desmond Yip Helped Build Cancer Care in the Solomon Islands

Gynecological Cancers, Cancer Vaccines & Immunotherapy: Are We Near Elimination?

Gynecological Cancers, Cancer Vaccines & Immunotherapy: Are We Near Elimination?

Annalice Gandini

GI News Updates with Annalice Gandini

Ringing the Bell Is Not the End of the Story, but the Beginning of a New One: Alejandra Méndez

Ringing the Bell Is Not the End of the Story, but the Beginning of a New One: Alejandra Méndez

Episode 15: Global Health Dialogues with Princess Dina and Dr Garo Armen

Episode 15: Global Health Dialogues with Princess Dina and Dr Garo Armen

Hisham Mehanna

What It Takes to Lead in Oncology Prof. Hisham Mehanna on Research, Mentorship & Life Balance

ASCO

ASCO 2026 with OncoDaily: Yvonne Awards, AI in Oncology, Grand Rounds and Live Coverage from Chicago

Lucica Ditiu

Ending Tuberculosis by 2030: Is It Still Possible? | Dr Lucica Ditiu

City-Level Cancer Care: A Missing Piece in the Puzzle?

City-Level Cancer Care: A Missing Piece in the Puzzle?

Empowering Oncologists: Why Survivorship Matters?

Empowering Oncologists: Why Survivorship Matters?

Not To Miss
EHA 2026 - OncoDaily

25 Posts Not To Miss From EHA 2026

25 Posts Not To Miss From EHA 2026

15 Posts Not To Miss From EACR 2026, Part 2

25 Posts Not To Miss From EACR 2026

Top Growing Medical Universities in Europe: 2026 Edition by BIGR

President’s Cancer Panel Meeting Focused on Modifiable Cancer Risk Factors and Prevention Opportunities

15 Posts Not To Miss From ASCO 2026: Breast Edition

OncoGrants
Global Ovarian Cancer Research Consortium AI Accelerator Grant — OCRA

Global Ovarian Cancer Research Consortium AI Accelerator Grant — OCRA

ACOG Foundation 2026 Request for Grant Proposals

ACOG Foundation 2026 Request for Grant Proposals

Clinical Trial Award — DoD OCRP

Clinical Trial Award — DoD OCRP

Ovarian Cancer Academy – Early-Career Investigator Award — DoD OCRP

Ovarian Cancer Academy – Early-Career Investigator Award — DoD OCRP

Investigator-Initiated Research Award — DoD Ovarian Cancer Research Program

Investigator-Initiated Research Award — DoD Ovarian Cancer Research Program

Kids Beating Cancer — John Voight Memorial Leukemia Research Grant

Kids Beating Cancer — John Voight Memorial Leukemia Research Grant

Oncologist near me
Oncologist Near Me

Oncologist Near Me – Gregory Kalemkerian: Advancing Lung Cancer Care, Research, and Education
Oncologist Near Me

Oncologist Near Me – Nagashree Seetharamu: A Journey of Healing, Mentorship, and Leadership
Oncologist Near Me

Oncologist Near Me – Paolo Tarantino: Shaping the Future of Breast Cancer Treatment
Oncologist Near Me

Oncologist Near Me – Rana McKay: A Rising Force in Genitourinary Cancer Research and Care
Oncologist Near Me

Oncologist Near Me – Razelle Kurzrock: Revolutionizing Cancer Treatment Through Precision Medicine
Oncologist Near Me

Oncologist Near Me – Yelena Janjigian: A Global Leader in Gastrointestinal Oncology
Oncologist Near Me

Oncologist Near Me – Bishal Gyawali: Challenging the Status Quo in Global Oncology
Oncologist Near Me

Oncologist Near Me – Yan Leyfman: A Voice for Innovation, Mentorship, and Impact in Oncology
Oncologist Near Me

Oncologist Near Me – Wafik S. El-Deiry: A Global Leader in Translational Oncology and Cancer Research
Oncologist Near Me

Oncologist Near Me – Enrique Soto: A Leader in Geriatric Oncology and Global Cancer Care

Cancer types
BPDCN

Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN): Current Perspectives on an Ultra-Rare Malignancy

Richter Transformation (RT): When Chronic Lymphocytic Leukemia Turns Aggressive

Acute Myeloid Leukemia (AML) in 2026: The Current Landscape and Future Perspectives

Follicular Lymphoma (FL): From Evolving Biology to Modern Therapeutic Paradigms

Hodgkin Lymphoma (HL): Microenvironmental Biology Behind a Therapeutic Success Story

Colorectal Cancer: Epidemiology, Pathogenesis, Diagnosis, and Therapeutic Advances

Cholangiocarcinoma: Latest Risk Factors, Symptoms, Diagnosis, and 2025 Advanced Treatment Options for Bile Duct Cancer

CancerWorld

Oncologists
Giuseppe Caruso

Giuseppe Caruso

Oncologists Location Milan, Italy
Tezer Kutluk

M. Tezer Kutluk

Oncologists Location Ankara, Türkiye
Nicholas DeVito

Nicholas DeVito

Oncologists Location Durham, USA
Wade Swenson

Wade Swenson

Oncologists Location Staples, USA
mahmoud hammad

Mahmoud Hammad

Oncologists Location Cairo, Egypt
Shikha Jain

Shikha Jain

Oncologists Location Chicago, USA
Christine Parseghian

Christine Parseghian

Oncologists Location Houston, USA
Cristina Smolenschi

Cristina Smolenschi

Oncologists Location Villejuif, France

Oncology Drugs
Sacituzumab Tirumotecan

Sacituzumab Tirumotecan: What Patients Should Know About This Emerging Cancer Treatment

Sacituzumab Tirumotecan: Clinical Development, Mechanism, and Emerging Role in Modern Oncology

Lurbinectedin: What Patients Should Know

Lurbinectedin in Oncology: Mechanism, Clinical Data, Evolving Role, and Future Directions

Bemarituzumab: What Patients with Gastric Cancer Should Know

Bemarituzumab: Uses in Cancer, Side Effects, Dosages, Expectations and More

GSK5764227 (HS-20093): A Novel B7-H3 Targeted Antibody–Drug Conjugate Under Clinical Investigation

OncoDaily Magazine

New Paper Alert
Cardiovascular Disease

Prevention And Management Of Cardiovascular Disease In Adults With Cancer: IC-OS And MASCC Clinical Practice Statement

EORTC–ESTRO

Endpoints in Metastases Directed Therapy for Oligometastatic Cancer A Review and Consensus by the EORTC–ESTRO OligoCare Consortium

MONTBLANC Trial

MONTBLANC Trial Recruitment Completed: Triple Immunotherapy in Advanced HCC

Clinical Trial

How Clinicians Can Truly Understand Clinical Trial Results?

OrigAMI-1 Trial

OrigAMI-1 Trial: Amivantamab in Refractory Metastatic Colorectal Cancer

Drug Discovery

Human-Centric New Approach Methodologies in Drug Discovery

OncoDaily Medical Journal

Hematology

10.69690/ODMJ-001-0526-7344

Analysis of Mortality Factors in the Pediatric Hemato-Oncology Department of the Children's Hospital of Rabat, 2022-2023
Original Research

Radiation Oncology

10.69690/ODMJ-011-0526-7409

An Independent Read-Only Verification and Risk-Management System to Maintain Radiotherapy Safety During Oncology Information System Failure
Case Reports/Brief Reports

Cancer Care

10.69690/ODMJ-001-0426-7451

Distinct differences in the tumour-resident microbiome between early- and late-onset colorectal cancer
Original Research

Hematology

10.69690/odmj-012-0426-7512

Frailty, infections, and bispecific antibodies in multiple myeloma: redefining supportive care in the era of T-cell redirection
Commentaries

Oncology Nursing

10.69690/ODMJ-002-0426-7359

Barriers and Facilitators of Oral Nutritional Supplement Adherence in Cancer: A Systematic Review
Review

Hematology

10.69690/ODMJ-011-0426-7452

Double Dilemma: Managing a Sequential Lymphoma (Case Report)
Case Reports/Brief Reports

Hematology

10.69690/ODMJ-011-0426-7442

Outcome of Hematopoietic Stem Cell Transplantation in Pediatric Patients with Severe Aplastic Anemia and Multi-Drug Resistant Bacterial Infections - A Case Series
Case Reports/Brief Reports

Oncology Nursing

10.69690/ODMJ-001-0404-7332

Enhancing Palliative Care Through Simulation-Based Workshops for Effective Symptom Management
Original Research